Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech SE ADR buy zonthiii

Start price
€85.01
16.11.20 / 50%
Target price
€85.00
16.11.21
Performance (%)
-12.20%
End price
€74.64
17.11.20
Summary
This prediction ended on 17.11.20 with a price of €74.64. The prediction for BioNTech SE ADR disappointed with a performance of -12.20%. zonthiii has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
BioNTech SE ADR 7.896% 7.896% 243.124% -
iShares Core DAX® 2.594% -1.158% 14.782% 16.813%
iShares Nasdaq 100 3.553% -1.727% 43.265% 44.227%
iShares Nikkei 225® 0.687% -8.354% 18.454% 1.361%
iShares S&P 500 2.209% -0.942% 31.361% 42.812%

According to zonthiii what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Capable Management
Differentiated customer and product portfolio
Growths faster than the competition
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Low dividend yield expected
negative Cash Flow expected
Significant cyclical dependencies

Comments by zonthiii for this prediction

In the thread Biontech SE diskutieren
Prediction Buy
Perf. (%) -12.20%
Target price 95.000
Change
Ends at 16.11.21

Buy mit Kursziel 95,0

Prediction Buy
Perf. (%) -12.20%
Target price 85.000
Change
Ends at 16.11.21

Kursziel geändert auf 85,0

In the thread Trading Biontech SE
Prediction Buy
Perf. (%) -12.20%
Target price 85.000
Change
Ends at 16.11.21

Buy beendet

Stopped prediction by zonthiii for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€76.21
18.11.20
€90.00
18.11.21
274.75%
20.08.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
BioNTech SE ADR

Start price
Target price
Perf. (%)
€74.64
17.11.20
€70.00
17.11.21
2.10%
18.11.20

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group